Cyclosporiasis outbreak hits Taco Bell sales, unlikely to cause lasting scar, analysts sayJuly 22, 2026
Share Facebook Twitter LinkedIn Pinterest Email Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic surgery device, clearing the way for the healthcare conglomerate to enter the soft-tissue robotic surgery market. Source Link amp authorization device FDA Johnson Johnson039s marketing robotic surgery
Cyclosporiasis outbreak hits Taco Bell sales, unlikely to cause lasting scar, analysts sayJuly 22, 2026
